GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,964,000 | +119.3% | 249,107 | +2.9% | 0.03% | +133.3% |
| Q2 2022 | $7,736,000 | -17.3% | 242,142 | -9.5% | 0.01% | 0.0% |
| Q1 2022 | $9,349,000 | +97.9% | 267,482 | +65.8% | 0.01% | +100.0% |
| Q4 2021 | $4,723,000 | +79.7% | 161,346 | +56.4% | 0.01% | +50.0% |
| Q3 2021 | $2,628,000 | -12.0% | 103,138 | +20.9% | 0.00% | 0.0% |
| Q2 2021 | $2,987,000 | +45.8% | 85,305 | +69.7% | 0.00% | +33.3% |
| Q1 2021 | $2,048,000 | -44.0% | 50,265 | -40.4% | 0.00% | 0.0% |
| Q4 2020 | $3,656,000 | -22.2% | 84,392 | +2.4% | 0.00% | -62.5% |
| Q3 2020 | $4,698,000 | +38.3% | 82,421 | +53.2% | 0.01% | +33.3% |
| Q2 2020 | $3,397,000 | +76.9% | 53,802 | +60.9% | 0.01% | +50.0% |
| Q1 2020 | $1,920,000 | -22.9% | 33,442 | +6.8% | 0.00% | 0.0% |
| Q4 2019 | $2,490,000 | +61.3% | 31,327 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $1,544,000 | -2.0% | 31,327 | +4.5% | 0.00% | 0.0% |
| Q2 2019 | $1,576,000 | +8.3% | 29,967 | +9.0% | 0.00% | 0.0% |
| Q1 2019 | $1,455,000 | – | 27,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 177,414 | $14,103,000 | 11.50% |
| Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
| Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
| ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
| STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
| Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
| Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
| Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
| SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
| Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |